University, PharmaTher Join Forces to Develop Ketamine for Rett | Rett Syndrome News
Case Western Reserve University is partnering with PharmaTher to develop and commercialize ketamine for the treatment of Rett Syndrome.| Rett Syndrome News
Case Western Reserve University is partnering with PharmaTher to develop and commercialize ketamine for the treatment of Rett Syndrome.| Rett Syndrome News
Treatment with esketamine, a compound related to ketamine, led to some behavioral improvements in three girls with Rett syndrome in a trial.| Rett Syndrome News
